Dr. Jens Lohrmann

Strategic leadership of Global Program Teams for the clinical development of cancer therapeutics through clinical proof-of-concept (PoC) for both small molecules and biologics; Developing the integrated strategic and operational development plan for clinical programs within Translational Clinical Oncology (TCO)

Seminal in developing & establishing the technical (CMC) development strategies in close collaboration with appropriate governance bodies and senior management for a novel, challenging crossfunctional drug class (Antibody Drug Conjugates), leading to several successful IND/IMPDs

Responsible for technical project leadership of global biopharmaceutical CMC development projects; Leading global multi-disciplinary CMC project teams with focus on optimizing value, time, resources and risks (contingency plans); Elaborate scientifically sound technical development strategies consistent with appropriate guidelines (e.g. ICH, EMA and FDA); Prioritize project activities and ensure progress against respective technical development plans (right quality and at the right time)

Bioanalytical expert in cross-functional CMC teams; Development and qualification of potency and bio-impurity assays; Method transfer and analytical comparability;

Company representative at seminars, conferences and trade fairs Customer- and Sales-support (scientific support of key-accounts) Acquisition and management of third-party funds, joint research projects and outsourcing projects Antibody Purification Service

Molekulare Signal-leitung und -netze; molekulare Entwicklungsbiologie und /Genetik; molekulare Pflanzenphysiologie;